Development and clinical validation of noninvasive diagnostics for mitochondrial disease

Ended Project Grant Awarded Last action

Award ID
W81XWH2210590
Recipient
Awarding agency
Obligated
$23,711,274

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $11,855,637.00 Federal
  • $11,855,637.00 Non-federal
Place of performance
Philadelphia, PA 19104, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Original award $11,855,637 $11,855,637

Subawards

Subrecipient Amount Awarded
The Trustees Of The University Of Pennsylvania In this grant, Penn will be responsible for fabricating biocompatible sensors for oxygen and other analytes of interest in the diagnosis of metabolic disease,… $132,638
The Trustees Of The University Of Pennsylvania Development and Clinical Validation of Noninvasive Diagnostics for Mitochondrial Disease: PROJECT 3 (Tomas S. Aleman et al.): Pupillometry coupled with… $89,505
The Trustees Of The University Of Pennsylvania In this grant, Penn will be responsible for fabricating biocompatible sensors for oxygen and other analytes of interest in the diagnosis of metabolic disease,… $129,429
The Trustees Of The University Of Pennsylvania $126,301

Quick answers

Who received award W81XWH2210590?

W81XWH2210590 was awarded to The Children's Hospital Of Philadelphia by Defense Health Agency (Department of Defense) on September 30, 2022.

How much is award W81XWH2210590 worth?

$23,711,274 has been obligated on W81XWH2210590: $11,855,637 in federal funding and $11,855,637 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award